Low uric acid in the blood, known clinically as hypouricemia, results from either reduced production of uric acid or increased excretion of it through the kidneys. Most people hear about uric acid only when it is too high, in the context of gout or kidney stones. But levels that drop below about 2 mg/dL can signal an underlying condition worth investigating, from inherited kidney transport defects to liver disease to medication side effects. The causes span a surprisingly wide range, and some carry real health consequences that are easy to overlook.
How Uric Acid Levels Stay in Range
Uric acid is the end product of purine metabolism. Purines are compounds found in every cell and in many foods, and when the body breaks them down, uric acid is what is left over. The liver handles most of the production side. The kidneys handle most of the elimination side, filtering uric acid out of the blood and then reabsorbing the majority of it back before the remainder leaves in urine. A smaller fraction exits through the gut. When something disrupts either production or kidney reabsorption, blood levels fall.
Because the system depends on both the liver making uric acid and the kidneys reclaiming most of it, low levels can trace back to problems at either end. The distinction matters because the causes, risks, and treatments differ depending on which mechanism is responsible.
Inherited Kidney Transport Defects
The most well-characterized genetic cause of low uric acid is renal hypouricemia, an inherited condition in which the kidneys fail to reabsorb uric acid properly. Instead of reclaiming the filtered uric acid and returning it to the blood, the kidney tubules let it pass into the urine in large quantities. The result is persistently low serum levels, sometimes well below 1 mg/dL.
Two genes are responsible for the vast majority of cases. The first identified was SLC22A12, which encodes a transporter called URAT1. More recently, mutations in a second gene, SLC2A9, which encodes a glucose transporter known as GLUT9, were confirmed to cause the same condition. Research has shown that GLUT9 mutations impair urate reabsorption on both sides of the renal proximal tubule cells, meaning uric acid that would normally be pulled back into the bloodstream instead ends up in the urine.1Elsevier / American Journal of Human Genetics. Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia
Renal hypouricemia is more common in certain populations, particularly among people of Japanese and Korean descent, where it has been studied most extensively. It tends to be inherited in an autosomal recessive pattern for URAT1 mutations, meaning a person needs to inherit a copy of the defective gene from each parent to develop the full condition. Carriers with just one copy may have mildly lower uric acid but usually have no symptoms.
Reduced Production From Enzyme Deficiencies
On the production side, the key enzyme is xanthine oxidase, which catalyzes the final steps of purine breakdown. Without it, the body cannot convert the intermediate compounds hypoxanthine and xanthine into uric acid. Hereditary xanthinuria is the classic example: a rare inherited deficiency of xanthine oxidase that results in very low serum uric acid along with elevated xanthine levels in the blood and urine.2ScienceDirect. Xanthinuria
Most people with hereditary xanthinuria never realize they have it. The condition is often discovered incidentally on a routine blood test. The main risk is xanthine kidney stones, which are uncommon but can occur because xanthine is less soluble than uric acid. Staying well hydrated and avoiding excessive purine intake are the usual recommendations, but many affected individuals go their entire lives without complications.
There are two subtypes. Type I involves a deficiency of xanthine oxidase alone. Type II involves a combined deficiency of xanthine oxidase and aldehyde oxidase, a related enzyme. The clinical picture is similar for both, though the biochemical profiles differ slightly in lab testing. A third form, called molybdenum cofactor deficiency, affects both enzymes plus sulfite oxidase and causes severe neurological problems in infancy. This last form is a very different clinical entity and far more serious than classic xanthinuria.
Medications That Lower Uric Acid
The most straightforward cause of low uric acid, and probably the most common in clinical practice, is medication. This typically happens in one of two ways: drugs prescribed specifically to lower uric acid overshoot their target, or drugs prescribed for unrelated conditions have uric acid lowering as a side effect.
Among the intentional urate-lowering drugs, the biggest culprits are xanthine oxidase inhibitors like allopurinol and febuxostat, uricosuric agents like probenecid and lesinurad, and uricases like rasburicase and pegloticase. Drug-induced hypouricemia most often occurs as overtreatment of high uric acid by these therapies.3SpringerLink. Drug-Induced Hypouricemia A patient on allopurinol for gout, for instance, may have their dose titrated upward to bring levels below a target threshold, and the result can be levels that drop lower than intended.
Unintentional uric acid lowering is a less recognized phenomenon. Certain antibiotics, high-dose salicylates (aspirin above about 3 grams per day), the diabetes drug SGLT2 inhibitors, and some contrast dyes used in imaging studies can all push uric acid levels down. Losartan, an angiotensin receptor blocker used for blood pressure, has a mild uricosuric effect that occasionally contributes. If your uric acid turns up low on a blood panel, one of the first things worth checking is whether any medication you take could be responsible.
Kidney Tubular Disorders
Beyond the inherited transporter mutations described above, acquired problems with the kidney tubules can also cause excessive uric acid loss. Fanconi syndrome is the textbook example. In this condition, the proximal tubules of the kidneys fail to reabsorb a wide range of substances, not just uric acid but also glucose, amino acids, phosphate, and bicarbonate. The result is a constellation of abnormalities on lab testing, including low blood uric acid.
In one documented case, a patient with adult-onset Fanconi syndrome had serum uric acid levels of just 1.5 to 1.8 mg/dL, with urate clearance running at roughly a third of the glomerular filtration rate, far above normal.4Elsevier / American Journal of the Medical Sciences. Hyperuricosuria in the Fanconi syndrome Fanconi syndrome can be inherited or acquired. Acquired forms are triggered by a range of insults including certain medications (tenofovir, used in HIV treatment, is a well-known cause), heavy metal exposure, and multiple myeloma.
The low uric acid in Fanconi syndrome is rarely the clinical priority. Phosphate wasting and acidosis tend to cause more immediate problems, including bone softening and muscle weakness. But recognizing the low uric acid as part of the pattern helps clinicians identify the tubular defect in the first place.
Liver Disease and Nutritional Factors
Because the liver is where most uric acid is produced, severe liver disease can reduce serum levels by limiting the organ’s capacity to synthesize purines and convert them to uric acid. This is most relevant in advanced cirrhosis or acute liver failure, where the liver’s metabolic functions are broadly compromised. Low uric acid in this context is usually one abnormality among many and is rarely the finding that raises the alarm.
Diet also plays a role. A very low protein or purine-restricted diet reduces the substrate available for uric acid production. Severe liver disease and low-protein or purine-restricted diets can decrease serum uric acid concentrations because of reduced hepatic purine synthesis.5ScienceDirect. Hypouricemia Malnutrition from any cause can have a similar effect. People with eating disorders, those on extreme elimination diets, and hospitalized patients who have been unable to eat for extended periods sometimes show unexpectedly low uric acid.
This nutritional mechanism is generally reversible. Once dietary intake improves, uric acid production picks back up and blood levels return to normal. The low reading itself is not dangerous in this scenario; it is more useful as a marker that nutritional status needs attention.
When Low Uric Acid Becomes Dangerous
Most people with mildly low uric acid have no symptoms at all, and the finding is often incidental. The danger comes with specific conditions, particularly hereditary renal hypouricemia, where the kidneys dump large amounts of uric acid into the urine. That creates two risks worth knowing about.
The first is kidney stones. When uric acid concentrations in the urine climb high enough, crystals can form and aggregate into stones. The risk is compounded in renal hypouricemia by the fact that some patients also have elevated urinary calcium, further promoting stone formation. While most patients with renal hypouricemia are asymptomatic, episodes of kidney stones and exercise-induced acute kidney injury are sometimes observed, and the increased risk of stones is linked to both high urinary uric acid and high urinary calcium.6PubMed Central. Exercise-Induced Acute Kidney Injury in a Police Officer with Hereditary Renal Hypouricemia
The second, more alarming risk is exercise-induced acute kidney injury. This has been reported in young, otherwise healthy individuals with renal hypouricemia who develop sudden kidney failure after intense physical activity. The mechanism is not fully understood, but it appears to involve a combination of concentrated uric acid in the kidney tubules, reduced blood flow during exertion, and possibly oxidative stress. Case reports describe athletes and military personnel who collapsed with kidney failure after strenuous exercise, only to discover afterward that they had an underlying urate transport defect.6PubMed Central. Exercise-Induced Acute Kidney Injury in a Police Officer with Hereditary Renal Hypouricemia
This exercise-related complication is rare, but it is the reason that incidentally discovered very low uric acid deserves follow-up testing rather than being dismissed. If the cause turns out to be a renal transport defect, the person benefits from knowing that extreme exertion poses a real, if uncommon, threat to their kidneys.
Other Medical Conditions Linked to Low Levels
Several systemic illnesses are associated with low uric acid, though the connection is not always straightforward. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) causes the body to retain water, diluting blood uric acid and simultaneously increasing its renal clearance. Low uric acid in the setting of low sodium can actually help clinicians distinguish SIADH from other causes of hyponatremia.
Certain cancers, particularly hematologic malignancies, can transiently lower uric acid in unusual ways, though they more commonly raise it. Intracellular purine stores can be depleted in rapidly dividing tumors that consume purines faster than the body produces them, although this is a less common scenario than the tumor lysis syndrome that sends uric acid skyrocketing during chemotherapy.
Wilson disease, a genetic disorder of copper metabolism, damages the kidney tubules and can mimic Fanconi syndrome, producing low uric acid alongside other tubular losses. In fact, unexplained low uric acid in a young person with liver problems should prompt consideration of Wilson disease, since early diagnosis of that condition can prevent irreversible organ damage.
The Uric Acid Antioxidant Question
One reason researchers have paid attention to low uric acid is the hypothesis that uric acid functions as an antioxidant in the blood. It accounts for a substantial share of the plasma’s antioxidant capacity, and some epidemiological studies have found associations between low uric acid and higher rates of certain neurodegenerative conditions, including multiple sclerosis and Parkinson disease. The idea is that people with lower circulating uric acid may have less protection against oxidative damage to nerve cells.
The evidence here is observational and far from settled. The associations could be driven by confounding factors rather than a true protective effect of uric acid. Clinical trials of uric acid supplementation in multiple sclerosis, for instance, have not produced convincing benefits. Still, this line of research is part of why clinicians have grown more interested in understanding what low levels mean, rather than treating them as universally benign. The antioxidant story is a reminder that uric acid is not simply metabolic waste; it has biological activity, and the consequences of very low levels remain an open question in the field.
How Low Uric Acid Is Investigated
When a blood test reveals low uric acid, the first step is usually a 24-hour urine collection to measure how much uric acid the kidneys are excreting. If urinary uric acid is high relative to what is in the blood, the problem is renal wasting: the kidneys are letting too much through. If urinary uric acid is also low, the problem is underproduction: the body is not making enough in the first place. This single test narrows the diagnostic possibilities considerably.
From there, the workup depends on context. A medication review is the easiest next step; if the patient is on allopurinol or a drug known to have uricosuric effects, the answer may be obvious. If there is no medication explanation and the pattern points to renal wasting, testing for Fanconi syndrome (by checking for phosphate, glucose, and amino acids in the urine) or genetic testing for URAT1 and GLUT9 mutations may be appropriate. If the pattern points to underproduction, xanthine levels in the urine can help diagnose xanthinuria, and liver function tests can evaluate hepatic causes.
In practice, many cases of mildly low uric acid on a single blood draw turn out to be clinically insignificant, driven by a recent change in diet, hydration status, or medication. Persistently low levels across multiple tests are the ones that warrant a closer look, especially if they are accompanied by kidney stones, unexplained kidney injury, or other tubular abnormalities on urinalysis.